Improved Oral Anticoagulation After a Dietary Vitamin K-Guided Strategy A Randomized Controlled Trial

被引:35
|
作者
de Assis, Michelli C. [1 ]
Rabelo, Eneida R. [1 ]
Avila, Christiane W. [1 ]
Polanczyk, Carisi Anne [1 ]
Rohde, Luis E. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Cardiol,Div Cardiovasc, Postgrad Program Cardiol & Cardiovasc Sci, BR-90035003 Porto Alegre, RS, Brazil
关键词
anticoagulants; diet; vitamin K; INTRACRANIAL HEMORRHAGE; RISK-FACTORS; WARFARIN; SENSITIVITY; SUPPLEMENTATION; VARIABILITY; STABILITY;
D O I
10.1161/CIRCULATIONAHA.109.849208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. Methods and Results-In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K- guided strategy based on simple modifications of the amount of vitamin K- rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n = 132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K- guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P = 0.04). Patients allocated to the dietary vitamin K- guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P = 0.06). Conclusions-A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR. (Circulation. 2009; 120: 1115-1122.)
引用
收藏
页码:1115 / U143
页数:11
相关论文
共 50 条
  • [21] Vitamin k1 versus vitamin K3 for prevention of subclinical vitamin deficiency:: A randomized controlled trial
    Chawla, D.
    Deorari, A. K.
    Saxena, R.
    Paul, V. K.
    Agarwal, R.
    Biswas, A.
    Meena, A.
    INDIAN PEDIATRICS, 2007, 44 (11) : 817 - 822
  • [22] Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial
    Wilson, SJA
    Wells, PS
    Kovacs, MJ
    Lewis, GM
    Martin, J
    Burton, E
    Anderson, DR
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 169 (04) : 293 - 298
  • [23] Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin
    Rondina, Matthew
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (12)
  • [24] Vitamin K prophylaxis for preterm infants: A randomized, controlled trial of 3 regimens
    Clarke, Paul
    Mitchell, Simon J.
    Wynn, Robert
    Sundaram, Shanmuga
    Speed, Valerie
    Gardener, Elizabeth
    Roeves, Donna
    Shearer, Martin J.
    PEDIATRICS, 2006, 118 (06) : E1657 - E1666
  • [25] Nutrigenetic-Guided Dietary Intervention and Weight Loss: A Randomized Controlled Feasibility Trial
    Egnatios, Jeremy
    Frankwich, Karen A.
    Kenyon, Mandy L.
    Rutledge, Thomas
    Liao, Patricia S.
    Gupta, Samir
    Herbst, Karen
    Zarrinpar, Amir
    GASTROENTEROLOGY, 2015, 148 (04) : S11 - S11
  • [26] Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial
    Jonas, Daniel E.
    Evans, James P.
    McLeod, Howard L.
    Brode, Shannon
    Lange, Leslie A.
    Young, Mary L.
    Shilliday, Betsy Bryant
    Bardsley, Michelle Martensen
    Swinton-Jenkins, Nia J.
    Weck, Karen E.
    PHARMACOGENOMICS, 2013, 14 (13) : 1593 - 1603
  • [27] Different vitamin K forms in hemodialysis patients: a simple dietary supplement to battle vascular calcification-randomized controlled trial
    Elshinnawy, Howaida Abdelhameed
    El-Said, Tamer Wahid
    Fahmy, Sarah Farid
    Shamseldin, Ahmed
    Ibrahim, Sherin
    Elsharabasy, Reem Mohsen
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01):
  • [28] Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy - A randomized, controlled trial
    Crowther, MA
    Douketis, JD
    Schnurr, T
    Steidl, L
    Mera, V
    Ultori, C
    Venco, A
    Ageno, W
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) : 251 - 254
  • [29] Oral vitamin A supplementation in very low birth weight neonates: a randomized controlled trial
    Sriparna Basu
    Parul Khanna
    Ragini Srivastava
    Ashok Kumar
    European Journal of Pediatrics, 2019, 178 : 1255 - 1265
  • [30] New Oral Anticoagulant Versus Vitamin K Antagonists for Thoracoscopic Ablation in Patients With Persistent Atrial Fibrillation: A Randomized Controlled Trial
    Lee, Yoonseo
    Jeong, Dong Seop
    Ahn, Joonghyun
    Park, Kyoung-Min
    Park, Seung-Jung
    Kim, June Soo
    On, Young Keun
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (02) : 268 - 274